Safety Study of X-82 in Patients With Advanced Solid Tumors
NCT01296581
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
X-82
Sponsor
Tyrogenex